Search Orphan Drug Designations and Approvals
-
Generic Name: | tobramycin liposomal for inhalation |
---|---|
Date Designated: | 04/14/2009 |
Orphan Designation: | Treatment of chronic pulmonary infection due to P. aeruginosa in cystic fibrosis patients |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Axentis Pharma AG 138 Limmatquai Zurich Switzerland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-